Skip to main content
. 2022 Jun 4;22:614. doi: 10.1186/s12885-022-09702-1

Table 4.

Methods, results, advantages and potential limitations of reported previous studies to evaluate metastasis involvement in breast cancer and the present study

Reference
First author, year
Methods Positive samples for metastatic breast cancer Samples with adequate number of tumor cells for receptor analysis Potential limitations
J. F. Hilton, 2011 [14] CT-guided bone biopsy 21/39(52.5%) 19/39(48.8%) Cannot confirm the location for tumors at the early stage
Wei Guo,2018 [6] PET/CT guided biopsy 46/54(85.2%) 23/46(50%) More expensive and less equipment
This study SPECT/CT guided bone biopsy 34/39(69%) 34/34(100%) 99mTc-MDP is not a specific tracer for metastatic disease